fda semaglutide shortage lawsuit FDA's GLP-1 decision kicks off 'unprecedented' tussle over FDA's Removal of Semaglutide and

Case reports and observational studies have documented instances where patients who followed standard fasting protocols had residual gastric contents visualized during endoscopy or present during anesthesia induction

however, DPP-IV expression on T cells from IBD patients is elevated

Diabetologia 48 , 22212228 (2005)

Discussion Our findings demonstrate that GLP-1 receptor-based therapeutics significantly disrupt the interoceptive stimulus effects of alcohol, highlighting a potential therapeutic mechanism through which these medications may reduce alcohol consumption and motivation

glycated hemoglobin is irreversibly bound to glucose, forming an advanced glycation end product (AGE)